Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(16 sites)
United States
Clinical Research Site, Little Rock, Arkansas Clinical Research Site, Santa Ana, California Clinical Research Site, Cromwell, Connecticut Clinical Research Site, Jacksonville, Florida Clinical Research Site, Orlando, Florida Clinical Research Site, Tampa, Florida Clinical Research Site, Atlanta, Georgia Clinical Research Site, Overland Park, Kansas Clinical Research Site, Louisville, Kentucky Clinical Research Site, Prairieville, Louisiana Clinical Research Site, Springfield, Missouri Clinical Research Site, Town and Country, Missouri Clinical Research Site, Tulsa, Oklahoma Clinical Research Site, Charleston, South Carolina Clinical Research Site, Memphis, Tennessee Clinical Research Site, Prosper, Texas